Protein Posttranslational Modifications in Glioma Stem Cells

Eiichi Hinoi1,2,3

  • 1Department of Bioactive Molecules, Pharmacology, Gifu Pharmaceutical University.

PubMed
Summary

Two protein modifications in glioma stem cells (GSCs) impact glioblastoma (GBM) malignancy. Understanding SMURF2 and MEK5 pathways offers potential therapeutic targets for cancers driven by cancer stem cells.